Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
24062 | Journal of Biotechnology | 2011 | 6 Pages |
MicroRNAs (miRNAs) are gaining recognition as essential regulators involved in many biological processes, and they are emerging as therapeutic targets for treating disease. Here, we introduce a method for effective delivery of anti-miRNA oligonucleotides (AMOs) using functionalized gold nanoparticles (AuNPs). To demonstrate the ability of AMOs to silence miRNA, we selected miR-29b, which is known to downregulate myeloid cell leukemia-1 (MCL-1), a factor responsible for promoting cell survival. We first generated AuNPs coated with cargo DNA, which was then coupled to complementary DNA linked to an antisense miR-29b sequence. When the AuNPs were delivered into HeLa cells, MCL-1 protein and mRNA levels were increased significantly. Furthermore, apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) was inhibited, proving that AMOs targeting miR-29b were effectively delivered by our innovative AuNP. In addition, we provided evidence that AuNP could deliver other AMOs against miR-21 into two independent cell lines, KGN and 293T, suggesting that the AuNP conjugates can be versatile for any AMO and cell type.
► Design of anti-miRNA oligonucleotides (AMOs) targeting miR-29b. ► Effective delivery of AMOs by functionalized gold nanoparticles (AuNP). ► AuNP-conjugated AMO-miR29b upregulates MCL-1 by blocking miR-29b. ► AuNP-conjugated AMO-miR29b protects against apoptotic stimulation with TRAIL.